Abstract:BackgroundPrevious studies have investigated the sustained aberrantly activated Interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) signaling pathway is crucial for pancreatic cancer growth and metastasis. Suppressor of cytokine signaling 3 (SOCS3), as a key negative feedback regulator of this signaling pathway, is usually down-regulated in various cancers. In the present study, we aim at exploring the biological function and the underlying molecular regulation mechanisms of SOCS3 in pancreatic cancer.MethodsThe expression of SOCS3 and other genes in pancreatic cancer was examined by Quantitative real-time PCR, western blotting and immunohistochemical staining. The interaction between pSTAT3 and DNA Methyltransferase 1 (DNMT1) was investigated by co-immunoprecipitation assay. Luciferase reporter assay was used to investigate the transcriptional regulation of pSTAT3 and DNMT1 on the SOCS3 gene. The effects of SOCS3 on the biological behavior of pancreatic cancer cells were assessed both in vitro and vivo. Furthermore, we performed a comprehensive analysis of the expression of SOCS3 in a pancreatic cancer tissue microarray (TMA) and correlated our findings with pathological parameters and outcomes of the patients.ResultsWe showed that SOCS3 expression was decreased in phosphorylated STAT3 (pSTAT3)-positive tumors and was negatively correlated with pSTAT3 in pancreatic cancer cells. We also found that IL-6/STAT3 promoted SOCS3 promoter hypermethylation by increasing DNMT1 activity; silencing DNMT1 or 5-aza-2-deoxycytidine (5-AZA) treatment could reverse the down-regulation of SOCS3 mediated by IL-6. Using co-immunoprecipitation and luciferase reporter assays, we found that STAT3 recruited DNMT1 to the promoter region of SOCS3 and inhibited its transcriptional activity. Overexpression of SOCS3 significantly inhibited cell proliferation, which may be due to the increase in G1-S phase arrest; overexpression of SOCS3 also inhibited cell migration and invasion as well as tumorigenicity in nude mice. Pancreatic cancer tissue microarray analysis showed that high SOCS3 expression was a good prognostic factor and negatively correlated with tumor volume and metastasis.ConclusionWe demonstrated that activated IL-6/STAT3 signaling could induce SOCS3 methylation via DNMT1, which led to pancreatic cancer growth and metastasis. These data also provided a mechanistic link between sustained aberrantly activated IL-6/STAT3 signaling and SOCS3 down-regulation in pancreatic cancer. Thus, inhibitors of STAT3 or DNMT1 may become novel strategies for treating pancreatic cancer.

Effect of the SOCS3 expression activates IL-6/STAT3 signal pathway via Abnormal methylation alteration of IL-6 in colorectal cancer

[DNA Methylation of ZIC1 and KLOTHO Gene Promoters in Colorectal Carcinomas and Its Clinicopathological Significance].

Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis

The Role and Gene Expression Profile of SOCS3 in Colorectal Carcinoma.

Expression and Biological Significance of SOCS3 and SOCS3 DNA Methylation in Oral Squamous Cell Carcinoma(OSCC)

Association between the Methylation of CpG Islands in JAK-STAT Pathway-Related Genes and Colorectal Cancer

Relationship Between SOCS3 and SOCS3 DNA Methylation with Esophageal Squamous Cell Carcinoma

Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.

[Down-Regulation of SOCS3 Expression by Methylation Correlates with Lymph Node Metastases of NSCLCs.].

IL-23 selectively promotes the metastasis of colorectal carcinoma cells with impaired Socs3 expression via the STAT5 pathway.

Expression of Socs-3 and Its Methylation in Renal Cancer

Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases

The Methylation of SOCS-1 Gene in Adult Acute Myeloid Leukemia

Association between SOCS gene hypermethylation and classical myeloproliferative neoplasms

Study on the Aberrant Methylation of SOCS-1 Gene in Diffuse Large B-cell Lymphoma

IL-13/STAT6 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Colorectal Cancer Cells.

Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer

SOCS3 as a potential driver of lung metastasis in colon cancer patients

Diagnostic Significance of Suppressor of Cytokine Signalling 3 (SOCS3) Methylation and Its Correlation with IDH1 Mutation in Chinese Glioma Patients

m<SUP>6</SUP>A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation

Knockdown of CTCF Reduces the Binding of EZH2 and Affects the Methylation of the SOCS3 Promoter in Hepatocellular Carcinoma.